Evidence map›Paper›PMID 23736765›Full record

ArticleMarine drugs2013

The extract of Rhodobacter sphaeroides inhibits melanogenesis through the MEK/ERK signaling pathway.

Wen-Sheng Liu, Yu-Diao Kuan, Kuo-Hsun Chiu, Wei-Kuang Wang, Fu-Hsin Chang, Chen-Hsun Liu, Che-Hsin Lee

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 42 citations in OpenAlex.

  1. Regulatory effects ofInternational journal of medical sciences · 2021
    Trial
  2. Applications of Probiotic Constituents in Cosmetics.Molecules (Basel, Switzerland) · 2023
    Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Anti-Pigmentary Natural Compounds and Their Mode of Action.International journal of molecular sciences · 2021
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. The Extracts ofInternational journal of medical sciences · 2017
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Wen-Sheng LiuAsia-Pacific Biotech Developing, Inc., Kaohsiung 806, Taiwan.
Yu-Diao Kuan
Kuo-Hsun Chiu
Wei-Kuang Wang
Fu-Hsin Chang
Chen-Hsun Liu
Che-Hsin Lee
China Medical University · TWFeng Chia University · TWI-Shou University · TWNational Kaohsiung Marine University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reducing hyperpigmentation has been a big issue for years. Even though pigmentation is a normal mechanism protecting skin from UV-causing DNA damage and oxidative stress, it is still an aesthetic problem for many people. Bacteria can produce some compounds in response to their environment. These compounds are widely used in cosmetic and pharmaceutical applications. Some probiotics have immunomodulatory activities and modulate the symptoms of several diseases. Previously, we found that the extracts of Rhodobacter sphaeroides (Lycogen™) inhibited nitric oxide production and inducible nitric-oxide synthase expression in activated macrophages. In this study, we sought to investigate an anti-melanogenic signaling pathway in α-melanocyte stimulating hormone (α-MSH)-treated B16F10 melanoma cells and zebrafish. Treatment with Lycogen™ inhibited the cellular melanin contents and expression of melanogenesis-related protein, including microphthalmia-associated transcription factor (MITF) and tyrosinase in B16F10 cells. Moreover, Lycogen™ reduced phosphorylation of MEK/ERK without affecting phosphorylation of p38. Meanwhile, Lycogen™ decreased zebrafish melanin expression in a dose-dependent manner. These findings establish Lycogen™ as a new target in melanogenesis and suggest a mechanism of action through the ERK signaling pathway. Our results suggested that Lycogen™ may have potential cosmetic usage in the future.

Indexed as

alpha-MSHAnimalsCell Line, TumorDose-Response Relationship, DrugHyperpigmentationMAP Kinase Signaling SystemMelaninsMelanoma, ExperimentalMiceMicrophthalmia-Associated Transcription FactorMonophenol MonooxygenasePhosphorylationRhodobacter sphaeroidesZebrafishalpha-MSHMelaninsMicrophthalmia-Associated Transcription FactorMonophenol Monooxygenase

Identifiers

PMID23736765
PMCPMC3721212
OpenAlexW2138986328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.